By Josh White
Date: Thursday 21 Mar 2024
(Sharecast News) - Digital brain health solutions developer Cambridge Cognition announced the creation of a scientific advisory board on Thursday.
By Josh White
Date: Wednesday 21 Feb 2024
(Sharecast News) - Brain health specialist Cambridge Cognition announced a strategic partnership with ActiGraph, a provider of wearable technologies tailored for clinical trials, on Wednesday.
By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Digital solutions group Cambridge Cognition has secured a "significant contract" for a "sizeable" later-stage clinical trial, following a competitive tender.
Currency | UK Pounds |
Share Price | 51.50p |
Change Today | -0.50p |
% Change | -0.96 % |
52 Week High | 104.00 |
52 Week Low | 48.80 |
Volume | 44,034 |
Shares Issued | 35.15m |
Market Cap | £18.10m |
RiskGrade | 282 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
10:42 | 487 @ 52.88p |
10:37 | 3,828 @ 51.99p |
09:28 | 2,000 @ 51.51p |
09:26 | 2,000 @ 51.99p |
09:20 | 13,769 @ 51.74p |
Chair | Steven John Powell |
CEO | Matthew Stork |
CFO | Stephen Symonds |
You are here: research